Attached files

file filename
EX-99.1 - EX-99.1 - CONMED Corpex99-1.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported): November 12, 2013

 

 

CONMED CORPORATION

(Exact name of registrant as specified in its charter)

 

 

New York 0-16093 16-0977505
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)
     

 

 

525 French Road

Utica, New York 13502

(Address of principal executive offices, including zip code)

 

 

 

(315) 797-8375

(Registrant's telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 7.01 Regulation FD Disclosure

 

On November 12, 2013, Mark E. Tryniski, Lead Independent Director of CONMED Corporation, sent the letter attached hereto as Exhibit 99.1 to Voce Capital Management, LLC.

 

Section 9 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.

 

(c)Exhibits

 

The following exhibit is included herewith:

 

 

  Exhibit No. Description of Exhibit
     
  99.1 Letter from Lead Independent Director dated November 12, 2013, issued by CONMED Corporation.
 
 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  CONMED CORPORATION
               (Registrant)
     
     
  By: /s/Robert D. Shallish, Jr.
        Robert D. Shallish, Jr.
        Executive Vice President-
    Finance & Chief Financial Officer

 

Date: November 12, 2013